Detalhe da pesquisa
1.
Long-acting cabotegravir pharmacokinetics with and without oral lead-in for HIV PrEP.
Antimicrob Agents Chemother
; : e0147523, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709006
2.
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.
Antimicrob Agents Chemother
; 67(4): e0005323, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36995219
3.
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
Lancet
; 399(10337): 1779-1789, 2022 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35378077
4.
"It's already in your body and it's preventing": a qualitative study of African female adolescent's acceptability and preferences for proxy HIV prevention methods in Cape Town, South Africa.
BMC Public Health
; 23(1): 2143, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37919697
5.
HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention.
J Infect Dis
; 226(12): 2170-2180, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240386
6.
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084.
J Infect Dis
; 225(10): 1741-1749, 2022 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35301540
7.
Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305).
AIDS Behav
; 26(12): 4107-4114, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35687192
8.
Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.
J Infect Dis
; 224(9): 1581-1592, 2021 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740057
9.
Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus-uninfected Individuals in HPTN 077.
Clin Infect Dis
; 70(2): 319-322, 2020 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31125395
10.
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077.
AIDS Behav
; 24(9): 2520-2531, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32052214
11.
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
PLoS Med
; 15(11): e1002690, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30408115
12.
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.
Ann Intern Med
; 167(6): 384-393, 2017 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28828489
13.
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).
J Infect Dis
; 215(2): 238-246, 2017 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27811319
14.
African Tick Bite Fever Treated Successfully With Rifampin in a Patient With Doxycycline Intolerance.
Clin Infect Dis
; 65(9): 1582-1584, 2017 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28505276
15.
Sustaining aquifers hydrologically, economically, and institutionally: Policy analysis of the Ogallala in New Mexico.
Sci Total Environ
; 921: 170727, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38350566
16.
Willingness and preferences for long-acting injectable PrEP among US men who have sex with men: a discrete choice experiment.
BMJ Open
; 14(4): e083837, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38653510
17.
Variation in Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis Among US Men Who Have Sex with Men: A Latent Class Analysis.
AIDS Patient Care STDS
; 37(10): 495-503, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37862078
18.
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial.
Lancet HIV
; 10(12): e767-e778, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952550
19.
Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial.
Lancet HIV
; 10(11): e703-e712, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37783219
20.
Are We Hitting the Target? HIV Pre-Exposure Prophylaxis from 2012 to 2020 in the OPERA Cohort.
AIDS Patient Care STDS
; 35(11): 419-427, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34609897